Medical weight management combines an individualized clinical evaluation with nutrition, physical activity, behavioral support, follow-up care, and prescription medication when appropriate.
At our Gilbert office, the program is provider led by Chad Dance, FNP-C, MSN, MS. Your provider will review your medical history, current medications, previous weight-management efforts, and treatment goals. Laboratory testing may be ordered when clinically appropriate.
Medication is not appropriate for every patient, and a consultation does not guarantee that a prescription will be provided. When medication is recommended, your provider will discuss available options, potential benefits and risks, alternatives, monitoring requirements, and applicable costs.
This page covers what medical weight loss is, which medications we prescribe, and how to know if you are a candidate. Most pricing information is listed on our services pricing page. To get started, call (480) 499-4441 or request a consultation.
Medical weight management may be an option for adults who have had difficulty achieving or maintaining their goals through lifestyle changes alone. Our providers offer straightforward guidance about available options, realistic expectations, potential risks, and the ongoing commitment involved.
Depending on the medication and its approved indication, treatment may be considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition, such as high blood pressure, prediabetes, or sleep apnea. BMI is only one part of determining eligibility. Your provider will also review your health history, current medications, previous treatments, and individual risk factors before recommending a plan.
Not every patient is a candidate for prescription weight-management medication. A consultation is required, and treatment is not guaranteed.
There are multiple medications on our menu. They work differently, cost differently, and produce different results. Here is what you need to know about each.
Semaglutide is a GLP-1 receptor agonist that supports appetite regulation, glucose management, and slower gastric emptying. FDA-approved medications containing Semaglutide include Wegovy, which is approved for chronic weight management in certain patients, and Ozempic, which has different approved uses.
Depending on a patient’s individual needs, a provider may discuss compounded Semaglutide as a treatment option. The medication is prepared by an FDA-registered 503A or 503B outsourcing facility operating under applicable federal manufacturing and compounding requirements. FDA registration of the facility does not mean that the compounded medication itself is FDA-approved.
Possible side effects include nausea, vomiting, diarrhea, abdominal discomfort, and constipation. Semaglutide may not be appropriate for patients with certain medical conditions, including a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
Your provider will review your medical history, current medications, treatment goals, and potential risks before determining whether Semaglutide may be appropriate. Individual experiences and results vary.
Tirzepatide acts on both GIP and GLP-1 receptors involved in appetite, glucose regulation, and digestion. FDA-approved medications containing Tirzepatide include Zepbound, which is approved for chronic weight management in certain eligible patients, and Mounjaro, which has different approved uses.
Depending on a patient’s individual needs, a provider may discuss compounded Tirzepatide as a treatment option. The medication is prepared by an FDA-registered 503A or 503B outsourcing facility operating under applicable federal manufacturing and compounding requirements. FDA registration of the facility does not mean that the compounded medication itself is FDA-approved.
Possible side effects include nausea, vomiting, diarrhea, constipation, decreased appetite, and abdominal discomfort. More serious risks may also occur, and Tirzepatide is not appropriate for everyone.
Your provider will review your medical history, current medications, treatment goals, potential risks, available alternatives, and cost considerations before determining whether Tirzepatide may be appropriate. Insurance coverage varies by medication, indication, and individual plan. Individual experiences and results vary.
An appetite suppressant taken as a daily oral medication. Phentermine is the oldest weight loss medication on our menu, FDA approved for short-term use. It is appropriate for patients who need rapid initial weight loss, patients with cardiovascular contraindications to GLP-1 medications, or patients who prefer pills to injections.
Phentermine works best as a 12-week intervention paired with diet and exercise. It is not appropriate for long-term use. Side effects include insomnia and elevated heart rate.
Human Chorionic Gonadotropin, or HCG, is a prescription hormone that has been used in medicine for many years. Over time, some HCG-associated protocols have been structured in phases that include preparation, a medically supervised reduced-calorie nutrition plan, and maintenance. The duration and level of monitoring depend on the individual patient and the provider’s clinical judgment.
It is important to note that HCG is not FDA-approved for weight loss, and current evidence has not established that it increases weight loss beyond the effects of calorie restriction alone. Highly restrictive diets may carry significant health risks and should only be considered with appropriate medical supervision.
Your provider will review your health history, treatment goals, potential risks, and available alternatives before determining which weight-management approach may be appropriate for you.
Don’t see what you’re looking for? Additional prescription and nonprescription weight-management options may be available based on your health history, treatment goals, previous experiences, and current medication availability.
Schedule a consultation to discuss which options may be appropriate for you. Your provider will review the potential benefits, risks, alternatives, and costs before recommending an individualized plan.
A clinical evaluation is required. Treatment and medication availability are not guaranteed.
You do not have to determine the right option on your own. That is the purpose of meeting with a provider.
During your consultation, your provider will review your medical history, current medications, previous weight-management efforts, treatment goals, preferences, and relevant risk factors. Insurance coverage and self-pay considerations may also be discussed.
Based on this evaluation, your provider will explain which treatment options may be appropriate, along with their potential benefits, risks, alternatives, monitoring requirements, and costs. If a particular medication is not appropriate or accessible, other evidence-based approaches may be considered. A consultation does not guarantee that medication will be prescribed, and individual results vary.
Our goal is to help you make an informed decision and develop a plan that reflects your individual needs.
For a broader overview of our medical weight-management services, visit our main weight-loss page.
We believe patients should have helpful cost information when considering medical weight management. Pricing for most of our services and programs is available on our services pricing page.
Some treatment costs vary based on the medication selected, dosage, program duration, monitoring needs, and individual treatment plan. Your provider will discuss applicable costs before treatment begins so you can make an informed decision.
We accept HSA and FSA payments for eligible services. Visit our current offers page for available new-patient promotions, eligibility requirements, and restrictions.
A consultation is required to determine which treatment options, if any, may be clinically appropriate. Pricing and medication availability are subject to change.
Your first visit takes about 30 minutes. Your provider reviews your medical history, performs a basic exam, orders baseline labs when appropriate, and walks through which medications fit your situation. If you decide to start that day, you can leave with a prescription or a medication-in-hand depending on the option you select.
Most patients see initial appetite changes within the first one to two weeks on GLP-1 medications. Measurable weight loss typically starts around weeks three to four. The full effect of dose-escalated Semaglutide or Tirzepatide takes about three to four months. Patience and Compliance matters with this process.
We schedule follow-up visits every four to six weeks during active treatment to monitor progress, adjust doses, and address any side effects. This is not a fire-and-forget prescription. It is a relationship with your provider.
Chad Dance, FNP-C, MSN, MS, is the clinician leading Keystone’s medical weight-management program. He works alongside the other nurse practitioners at our Gilbert and Mesa Eastmark locations to support consistent, individualized patient care.
Chad earned master’s degrees from the University of Phoenix and Idaho State University and has more than thirteen years of combined nursing and nurse practitioner experience. Before becoming a nurse practitioner, he spent more than five years as an ICU nurse at a Level II trauma center, caring for patients with complex medical, surgical, neurological, and cardiac needs.
His critical-care background contributes to the program’s emphasis on careful evaluation, medication management, patient education, and ongoing monitoring. Depending on scheduling and location, patients may be seen by Chad or another licensed Keystone nurse practitioner.
Chad is fluent in conversational and medical Spanish. Patients may request a Spanish-language appointment when scheduling, subject to provider availability. Habla español.
Our Gilbert office is at 3076 East Chandler Heights Road, Suite 115, in south Gilbert. We are about five minutes from Mercy Gilbert Medical Center and ten minutes from San Tan Village. Many of our weight loss patients come from Power Ranch, Seville, Adora Trails, Trilogy at Power Ranch, Coronado Ranch, Country Shadows, and the surrounding master-planned communities.
We also serve patients from Queen Creek and east Chandler. The drive from most parts of Queen Creek is under fifteen minutes. From east Chandler, even less. If you would prefer our Mesa Eastmark office, that location offers the same weight loss program with the same provider.
3076 E. Chandler Heights Road, Suite 115, Gilbert, AZ 85298
Located on the south side of Chandler Heights Road, just east of Greenfield Road. Get Directions
Phone: (480) 499-4441
Pricing for many of our medical weight-management services is available on our services pricing page. Final costs vary based on the treatment selected, dosage, program duration, monitoring needs, and individualized care plan.
We accept HSA and FSA payments for eligible services. Your provider will review treatment options and associated costs before treatment begins.
Weight loss varies by patient and depends on factors such as the specific medication and formulation, dosage, treatment duration, starting weight, medical conditions, treatment response, and lifestyle habits.
Clinical trials of FDA-approved products containing semaglutide or tirzepatide have reported average weight reduction in certain study populations. Individual outcomes varied, and clinical-trial results should not be assumed to apply to compounded formulations.
Your provider will discuss realistic expectations, monitor your progress, and adjust your treatment plan when clinically appropriate. Individual results vary, and no specific amount or rate of weight loss can be guaranteed.
Semaglutide acts on GLP-1 receptors, while Tirzepatide acts on both GIP and GLP-1 receptors. Both medications influence appetite, glucose regulation, and digestion through different mechanisms.
Clinical trials of specific FDA-approved products have reported different average weight-loss outcomes in studied populations. However, those results depend on the formulation, dosage, treatment duration, and patient population and should not be assumed to apply to compounded formulations or predict an individual patient’s results.
The appropriate option depends on your medical history, current medications, previous treatment response, potential risks, treatment goals, product availability, insurance coverage, and cost considerations. Your provider will review these factors with you before recommending a treatment plan. Individual results vary.
The timing and amount of weight loss vary by patient. Some patients may notice changes in appetite or eating patterns during the early stages of treatment, while changes in weight may develop more gradually.
Results depend on factors such as the medication and formulation used, dosage, dose-adjustment schedule, starting weight, medical conditions, treatment response, and lifestyle habits. Reaching an appropriate dose may take time, and continued progress depends on the individual treatment plan.
Your provider will monitor your response, discuss realistic expectations, and adjust treatment when clinically appropriate. Medical weight management is an ongoing process, and no specific timeline or result can be guaranteed.
Yes. Semaglutide and Tirzepatide are prescription medications that require an individualized evaluation by a licensed medical provider.
During your consultation, your provider will review your medical history, current medications, treatment goals, potential contraindications, and other relevant risk factors. Laboratory testing may be ordered when clinically appropriate. If medication is prescribed, follow-up and monitoring will be based on your individual treatment plan.
Keystone does not prescribe Semaglutide or Tirzepatide without an appropriate clinical evaluation. A consultation does not guarantee that either medication will be prescribed.
Semaglutide and Tirzepatide can cause side effects. Commonly reported effects include nausea, vomiting, diarrhea, constipation, abdominal discomfort, decreased appetite, and fatigue. Side effects may occur when treatment begins or after a dose adjustment, but their timing, duration, and severity vary by patient.
More serious risks may include pancreatitis, gallbladder problems, dehydration-related kidney injury, severe gastrointestinal reactions, low blood sugar when used with certain diabetes medications, and serious allergic reactions.
These medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Other warnings, contraindications, and medication interactions may apply.
This is not a complete list of potential side effects or risks. Your provider will review your medical history and current medications, screen for relevant risk factors, and discuss the specific formulation before determining whether treatment may be appropriate.
Yes. Depending on your clinical needs, non-injection options may be available. For certain eligible patients, a provider may consider Phentermine, an oral prescription medication FDA-approved as a short-term adjunct to nutrition, physical activity, and behavioral changes.
Nutrition planning, lifestyle support, and ongoing clinical monitoring may also be incorporated into a weight-management plan without injectable medication.
Phentermine is not appropriate for everyone and has important contraindications and potential side effects. Your provider will review your medical history, current medications, blood pressure, risk factors, and treatment goals before recommending any option. A consultation does not guarantee that medication will be prescribed.
Insurance coverage for weight loss medications varies widely. We are an out-of-network practice and do not bill insurance directly. We accept HSA, FSA, and offer financing options.
Depending on the treatment and its approved indication, prescription weight-management medication may be considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition, such as high blood pressure, prediabetes, or sleep apnea.
BMI is only one part of determining eligibility. Your provider will also review your medical history, current medications, previous weight-management efforts, treatment goals, potential contraindications, and individual risk factors.
Medical weight management generally works best as an ongoing process that includes follow-up care and sustainable lifestyle changes. Not every patient is a candidate for every medication, and a consultation does not guarantee that treatment will be prescribed.
The ideal patient is someone who is willing to commit to follow-up visits and lifestyle adjustments. They want a provider relationship, not a vending machine for medication.
Call (480) 499-4441 or request a consultation online. Same-week appointments are usually available.
Keystone Medical Wellness, Gilbert
3076 E. Chandler Heights Road, Suite 115
Gilbert, AZ 85298
(480) 499-4441